Our proprietary test offering includes lipoprotein subfractionation analyses, advanced cardiovascular risk markers and genetic tests that determine risk characteristics with precision and accuracy. Based on these analyses, clinicians are able to create personalized treatment plans for each patient. To learn more about the advanced testing we provide, please review the Test Descriptions section.

The Berkeley HeartLab test precisely measures discriminating increments in lipoproteins with statistical certainty. The precision we offer allows for the monitoring of changes in a patient's risk over time, giving clinicians insight to adjust treatment plans accordingly.

Our 4myheart Program for disease management connects a patient with a Berkeley HeartLab Clinical Educator (CE). The CE's educational focus with the patient is on their test results, their doctor's treatment plan and the lifestyle changes that can reduce their cardiovascular disease (CVD) and stroke risk as identified and monitored by the Berkeley HeartLab test.

We employ a proprietary approach using personalization, reminder systems, and community to drive this program. Patients in the 4myheart Program are more likely to make progress toward their risk reduction goals and to adopt better nutrition, appropriate exercise, stress management techniques, and adhere to their clinician's prescriptions.

Our comprehensive educational approach in the 4myheart Program empowers patients to make changes, resulting in better clinical outcomes and quality of life improvement.